In Q1'26, CVS's operating cash flow reached $4.25B USD, reflecting a robust increase from the prior quarter's $3.39B USD and marking one of the strongest quarterly performances in the observed period. Free cash flow for the same quarter stood at $3.4B USD, up from $2.61B USD in Q4'25, indicating improved liquidity after capital expenditures. Over the period from Q2'23 to Q1'26, operating cash flow exhibited significant volatility, with peaks of $5.91B USD in Q2'23 and $4.55B USD in Q1'25 contrasting sharp declines to -$2.64B USD in Q4'23 and -$745M USD in Q3'24, suggesting seasonal or operational fluctuations in core business activities. Free cash flow followed a similar erratic pattern, ranging from a low of -$3.55B USD in Q4'23 to highs of $5.32B USD in Q2'23 and $4.2B USD in Q1'24, with an overall upward trajectory in recent quarters driven by better cash generation efficiency, though persistent negative periods highlight ongoing challenges in capital management.